Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
17.00
+0.20 (1.19%)
At close: Apr 23, 2025
Market Cap 343.86M
Revenue (ttm) 53.00K
Net Income (ttm) -105.16M
Shares Out 20.23M
EPS (ttm) -85.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 38,347
Average Volume 17,923
Open 16.80
Previous Close 16.80
Day's Range 15.82 - 17.80
52-Week Range 1.57 - 124.60
Beta n/a
RSI 52.60
Earnings Date Apr 2, 2025

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.